Journal Article

DKFZ-2024-01522

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level.

Godbole, S. ; Voß, H. ; Gocke, A. ; Schlumbohm, S. ; Schumann, Y. ; Peng, B. ; Mynarek, M. ; Rutkowski, S. ; Dottermusch, M. ; Dorostkar, M. M. ; Korshunov, A.DKFZ* ; Mair, T. ; Pfister, S.DKFZ* ; Kwiatkowski, M. ; Hotze, M. ; Neumann, P. ; Hartmann, C. ; Weis, J. ; Liesche-Starnecker, F. ; Guan, Y. ; Moritz, M. ; Siebels, B. ; Struve, N. ; Schlüter, H. ; Schüller, U. ; Krisp, C. ; Neumann, J. E.

2024
Nature Publishing Group UK [London]

This record in other databases:  

Please use a persistent id in citations: doi:10.1038/s41467-024-50554-z

Abstract: Medulloblastomas (MBs) are malignant pediatric brain tumors that are molecularly and clinically heterogenous. The application of omics technologies-mainly studying nucleic acids-has significantly improved MB classification and stratification, but treatment options are still unsatisfactory. The proteome and their N-glycans hold the potential to discover clinically relevant phenotypes and targetable pathways. We compile a harmonized proteome dataset of 167 MBs and integrate findings with DNA methylome, transcriptome and N-glycome data. We show six proteome MB subtypes, that can be assigned to two main molecular programs: transcription/translation (pSHHt, pWNT and pG3myc), and synapses/immunological processes (pSHHs, pG3 and pG4). Multiomic analysis reveals different conservation levels of proteome features across MB subtypes at the DNA methylome level. Aggressive pGroup3myc MBs and favorable pWNT MBs are most similar in cluster hierarchies concerning overall proteome patterns but show different protein abundances of the vincristine resistance-associated multiprotein complex TriC/CCT and of N-glycan turnover-associated factors. The N-glycome reflects proteome subtypes and complex-bisecting N-glycans characterize pGroup3myc tumors. Our results shed light on targetable alterations in MB and set a foundation for potential immunotherapies targeting glycan structures.

Keyword(s): Medulloblastoma: metabolism (MeSH) ; Medulloblastoma: genetics (MeSH) ; Humans (MeSH) ; Polysaccharides: metabolism (MeSH) ; Proteome: metabolism (MeSH) ; Cerebellar Neoplasms: metabolism (MeSH) ; Cerebellar Neoplasms: genetics (MeSH) ; DNA Methylation (MeSH) ; Transcriptome (MeSH) ; Child (MeSH) ; Proteomics: methods (MeSH) ; Female (MeSH) ; Gene Expression Regulation, Neoplastic (MeSH) ; Male (MeSH) ; Child, Preschool (MeSH) ; Gene Expression Profiling: methods (MeSH) ; Polysaccharides ; Proteome

---

Contributing Institute(s):

1. KKE Neuropathologie (B300)
2. DKTK HD zentral (HD01)
3. B062 Pädiatrische Neuroonkologie (B062)

Research Program(s):

1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2024

---

Database coverage:
; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Agriculture, Biology and Environmental Sciences ; Current Contents - Life Sciences ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 15 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record

---